Kelly leads the accounting and finance team at Inhibrx and is responsible for all internal and external reporting requirements, as well as day-to-day accounting activities. Kelly joined Inhibrx in October 2018, bringing with her over 15 years of experience in the life science industry. Prior to joining Inhibrx, Kelly held various accounting and finance positions of increasing responsibility with Apricus Biosciences, Inc., Hologic Inc., Gen-Probe, Inc., and Cytori Therapeutics, Inc. Kelly has a B.S. and M.S. in Accounting and is an active licensed Certified Public Accountant in the state of California.